Gabather AB (publ) (GABA.ST)

SEK 0.4

(-3.61%)

Market Cap (In SEK)

9.48 Million

Revenue (In SEK)

-

Net Income (In SEK)

-9.43 Million

Avg. Volume

23.38 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.365-2.98
PE
-
EPS
-
Beta Value
0.41
ISIN
SE0010869552
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Michael-Robin Witt
Employee Count
-
Website
https://www.gabather.com
Ipo Date
2014-11-03
Details
Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was incorporated in 2014 and is based in Södertälje Sweden.